ZILIA OCULAR

EUIPO EUIPO 2022 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark ZILIA OCULAR was filed as Word mark on 04/06/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 08/18/2022. The current status of the mark is "Trademark registered".

Trademark Details Last update: August 22, 2022

Trademark form Word mark
File reference 018683076
Application date April 6, 2022
Publication date May 11, 2022
Entry date August 18, 2022
Expiration date April 6, 2032

Trademark owner

125, boulevard Charest Est, Bureau 400
G1K 3G5 Québec
CA

Trademark representatives

Magnus Ladulåsgatan 63B 118 26 Stockholm SE

goods and services

9 computer software for medical imaging; computer software for use in the evaluation and analysis of data utilizing machine learning; computer software for database management; computer software for controlling and managing patient medical information; computer software allowing analysis of biological tissues and biomarkers data for medical diagnostic, testing and examination purposes
10 Diagnostic biomarker testing apparatus for use in diagnosis of eye disease; medical diagnostic apparatus for detecting biomarkers in eye fluid; fundus cameras being medical instruments; retinal cameras for medical use; retinal examination equipment for medical testing and examination purposes; medical diagnostic testing apparatus and instruments for processing, reading and analyzing biomarkers for diagnosis and testing of eye diseases and disorders, neurologic diseases and conditions, cardiovascular diseases and conditions, and cancers; ocular oximeters for medical diagnostic
42 Biomedical research; design and development of computer software; cloud computing providing software for database management; Software as a Service (SaaS) for database management; Software as a Service (SaaS) for use in the evaluation and analysis of data utilizing machine learning; providing software as a service (SaaS) for controlling and managing patient medical information; providing software as a service (SaaS) for use in calculating, transferring and storing data relating to the diagnosis and treatment of eye diseases and disorders, neurologic diseases and conditions, cardiovascular diseases and conditions, and cancers; providing software as a service (SaaS) allowing analysis of biological tissues and biomarkers data for medical diagnostic, testing and examination purposes

Trademark history

Date Document number Area Entry
August 19, 2022 Change Representative, Published

ID: 11018683076